Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicity
4-dinitrophenyl)sulfonyl)piperazin-1-yl)quinoline
(2011) Cell Signal
987 is not suitable for use in humans because of excessive inhibition of the hERG antitarget
Studies in vitro suggest that it binds to a regulatory site on the CB1 receptor target
Enrofloxacin Catalog No.:M8968-2 A novel G418 conjugate resultsEnrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation. It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration dependent, with susceptible bacteria cell death occurring within 2030 minutes of exposure. Enrofloxacin has demonstrated a significant post antibiotic effect for both Gram negative and Gram positive bacteria and is active in both stationary and growth phases of bacterial replication. Product
US$ 50.00
US$ 15.00